TLPH Price / Book | TALPHERA, INC.

TALPHERA, INC. (TLPH) Price / Book

2026-09-03: Price/Book Ratio 4.34.
2026-06-30: Price/Book Ratio 3.71.
2026-03-31: Price/Book Ratio 2.03.
2025-12-31: Price/Book Ratio 3.3.

Historical market capitalization divided by filed shareholder equity.

Available history: 2011-06-30 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	4.34
2026-06-30	3.71
2026-03-31	2.03
2025-12-31	3.3
2025-09-30	2.12
2025-06-30	1.42
2025-03-31	1.53
2024-12-31	1.11
2024-09-30	1.52
2024-06-30	1.19
2024-03-31	1.07
2023-12-31	0.89
2023-09-30	0.54
2023-06-30	1.17
2023-03-31	0.51
2022-12-31	0.85
2022-09-30	1.14
2022-06-30	21.34
2018-12-31	855.54
2016-09-30	1,077.92
2016-06-30	180.6
2016-03-31	119.06
2015-12-31	105.28
2015-09-30	67.84
2015-06-30	112.69
2015-03-31	83.31
2014-12-31	126.11
2014-09-30	81.23
2014-06-30	160.07
2014-03-31	159.91
2013-12-31	133.11
2013-09-30	174.41
2013-06-30	1,148.95
2013-03-31	175.29
2012-12-31	93.28
2012-06-30	192.79
2012-03-31	124.6
2011-12-31	43.02
2011-09-30	53.75
2011-06-30	62.74

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
CalciMedica, Inc. (CALC)	United States	$0.061B	-1.42
Skye Bioscience, Inc. (SKYE)	United States	$0.061B	-0.48
Boundless Bio, Inc. (BOLD)	United States	$0.059B	-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)	United States	$0.058B
Rein Therapeutics, Inc. (RNTX)	United States	$0.063B	-1.76
Annovis Bio, Inc. (ANVS)	United States	$0.056B	-1.58
HYPERION DEFI, INC. (HYPD)	United States	$0.065B
XBiotech Inc. (XBIT)	United States	$0.066B	-1.56
HERON THERAPEUTICS, INC. /DE/ (HRTX)	United States	$0.055B	-2.38
Clene Inc. (CLNN)	United States	$0.054B	-1.99